常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-3.86/-0.63
|
|
企业价值
28.28M
|
| 资产负债 |
|
每股账面净值
1.40
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
500.00K
|
|
每股收益
3.77
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2025/11/16 02:43 EST
同行比较之报价最少15分钟延迟
|
业务概览
|
|||
| Exicure Inc is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. It operates in a single segment which is Biotechnology. |

3.71 
